AbbVie (ABBV) Revenue (2011 - 2025)

AbbVie (ABBV) has 15 years of Revenue data on file, last reported at $61.2 billion in FY2025.

• Revenue for Q1 2026 came in at $15.0 billion, up 12.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $62.8 billion (up 9.5% YoY), and the FY2025 annual result was $61.2 billion, up 8.57% from the prior year.
• Revenue climbed to $61.2 billion in FY2025 per ABBV's latest filing, from $56.3 billion in the prior year.
• Over five years, Revenue peaked at $61.2 billion in FY2025 and troughed at $54.3 billion in FY2023.
• A 5-year average of $57.2 billion and a median of $56.3 billion in 2024 frame the typical range for Revenue.
• The sharpest annual moves came in 2021 and 2023: Revenue grew 22.69% in 2021, then slipped 6.44% in 2023.
• A 5-year view of Revenue shows it stood at $56.2 billion in 2021, then advanced by 3.3% to $58.1 billion in 2022, then decreased by 6.44% to $54.3 billion in 2023, then increased by 3.71% to $56.3 billion in 2024, then grew by 8.57% to $61.2 billion in 2025.
• Business Quant data shows ABBV's Revenue at $61.2 billion in FY2025, $56.3 billion in FY2024, and $54.3 billion in FY2023.